The Conversation – The big question scientists are wrestling with is whether these genome editing technologies should be used to make modifications in human reproductive cells, which would be heritable from one generation to the next.
Wisc News - “Up until now, we’ve been talking only hypothetically and most people assumed we simply wouldn’t ever do this…We are not saying that you have to or you should, but we are saying that if you can meet these criteria it is permissible.”
TechCrunch - The important piece for Doudna is that everyone can at least start to move forward in applying the technology. “In the end, as scientists, we would all like to see this technology help people and ultimately that’s got to be the goal that we all have.”
The New York Times – A science advisory group formed by the National Academy of Sciences and the National Academy of Medicine lent its support to a once-unthinkable proposition: clinical efforts to engineer humans with inheritable genetic traits.
Forward – Perlmutter’s DNA is at the center of an outlandish lawsuit that could have important legal ramifications. According to circuit judge Meenu Sasser, “no binding authority has ever definitively answered the question of whether genetic material such as DNA constitutes ‘property.’”